Enzicord 300 Capsule contains Coenzyme Q10 (300 mg), a vital antioxidant naturally present in the mitochondria of cells, playing a crucial role in cellular energy production through the electron transport chain. This supplement is indicated for patients requiring support in managing conditions associated with Coenzyme Q10 deficiency, such as mitochondrial disorders, cardiovascular diseases, and certain neurodegenerative conditions. Enzicord 300 aids in enhancing myocardial energy metabolism, thereby improving cardiac function and reducing symptoms related to congestive heart failure, ischemic heart disease, and hypertension. Additionally, it may provide adjunctive benefits in statin-induced myopathy by replenishing depleted Coenzyme Q10 levels. The antioxidant properties of Coenzyme Q10 help mitigate oxidative stress, potentially slowing the progression of age-related diseases and improving overall cellular health. Enzicord 300 is administered orally, with dosage tailored according to clinical indication and patient response. It is generally well tolerated, with minimal adverse effects reported, though occasional gastrointestinal discomfort may occur. Contraindications include hypersensitivity to Coenzyme Q10 or any capsule excipients. Caution is advised when co-administered with anticoagulants due to potential interaction affecting coagulation parameters. Enzicord 300 Capsule should be used under medical supervision to ensure optimal therapeutic outcomes.